Table 1.

Comparison of success in glucose control between patients with BPH treated and untreated with/without diabetes

	Diabetes	Prostate	Prostate drug	Total patients	Treatment success*	Treatment fail
Group1	+	+	−	253	151 (60%)	102
Group2	+	−	−	246	119 (48%)	127

Out of 26 537 patients diagnosed with BPH there were 5756 patients who did not receive α1‐adrenoceptor antagonists. Out of these patients, 253 were diagnosed with type 2 diabetes. Matched with a group of 246 type 2 diabetes patients who were not diagnosed with BPH, there was no statistically significant difference of improved success rate (P = .06).

^* P = .06.